OncoAide delivers clinically validated genomic and pathology testing, liquid-biopsy monitoring and personalised therapeutic recommendations to patients and clinicians.
Targeted panels (50–500+ genes), exome & whole-genome options with actionable variant reports.
Non-invasive ctDNA testing for treatment monitoring and early relapse detection.
AI-assisted pathology for PD-L1, MSI, TMB and other immuno-oncology markers.
Evidence-based treatment recommendations and clinical-trial matching.
GMP-grade cell processing and release testing for autologous therapies.
Custom panels, biomarker discovery and regulatory support for pharma partners.
Clinicians order via our secure portal; informed consent & sample forms provided.
Blood, tissue or liquid-biopsy samples collected at partner centres with cold-chain logistics.
ISO/NABL labs run NGS, ctDNA assays and AI pathology under strict QA.
Actionable report delivered within 72 hrs; optional molecular tumour-board review.
Secure login for streamlined test ordering, sample tracking, raw-data access and MDT-ready reports. Priority processing for hospital partners and API integration for EMRs.
Coverage varies; we provide documentation for pre-authorisation and claims support.
Standard panels: 48–72 hrs after sample receipt; complex tests may take longer.
Yes. Encrypted storage, strict access controls and compliance with data-protection laws.
Ready to start? Reach our support team for test bookings, sample logistics or clinician portal access.